Urologische Klinik und Poliklinik » Forschung » Publikationen 2012

Publikationen 2012

[Image-guided punch biopsy of the prostate].
Aktuelle Urol. 2012;43(5): 321-9
Seitz M, Gratzke C, Stief C, Tilki D

Is there a significance of histamine in the control of the human male sexual response?
Andrologia. 2012;44 Suppl 1: 538-42
Uckert S, Wilken M, Stief C, Trottmann M, Kuczyk M, Becker A

Predictors of Survival in Patients With Soft Tissue Surgical Margin Involvement at Radical Cystectomy.
Ann Surg Oncol. 2012; [Epub ahead of print]
Xylinas E, Rink M, Novara G, Green DA, Clozel T, Fritsche HM, Guillonneau B, Lotan Y, Kassouf W, Tilki D, Babjuk M, Karakiewicz PI, Montorsi F, Abdennabi J, Trinh QD, Svatek RS, Scherr DS, Zerbib M, Shariat SF

Functional interactions between the fossa ischioanalis, levator ani and gluteus maximus muscles of the female pelvic floor: a prospective study in nulliparous women.
Arch Gynecol Obstet. 2012;286(4): 931-8
Soljanik I, Janssen U, May F, Fritsch H, Stief CG, Weissenbacher ER, Friese K, Lienemann A

Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy.
BJU Int. 2012; [Epub ahead of print]
Chromecki TF, Cha EK, Fajkovic H, Rink M, Ehdaie B, Svatek RS, Karakiewicz PI, Lotan Y, Tilki D, Bastian PJ, Daneshmand S, Kassouf W, Durand M, Novara G, Fritsche HM, Burger M, Izawa JI, Brisuda A, Babjuk M, Pummer K, Shariat SF

The effect of clinical trial participation versus non-participation on overall survival in men receiving first-line docetaxel-containing chemotherapy for metastatic castration-resistant prostate cancer.
BJU Int. 2012; [Epub ahead of print]
Goyal J, Nuhn P, Huang P, Tyagi P, Oh D, Carducci MA, Eisenberger MA, Antonarakis ES

Real-time magnetic resonance imaging (MRI): anatomical changes during physiological voiding in men.
BJU Int. 2012;109(2): 234-9
Hocaoglu Y, Roosen A, Herrmann K, Tritschler S, Stief C, Bauer RM

Prognostic role of ECOG performance status in patients with urothelial carcinoma of the upper urinary tract: an international study.
BJU Int. 2012;109(8): 1155-1161
Martinez-Salamanca JI, Shariat SF, Rodriguez JC, Chromecki TF, Ficarra V, Fritsche HM, Kassouf W, Matsumoto K, Cabello LO, Seitz C, Tritschler S, Walton TJ, Zattoni F, Novara G

Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy.
BJU Int. 2012; [Epub ahead of print]
Rink M, Hansen J, Cha EK, Green DA, Babjuk M, Svatek RS, Xylinas E, Tagawa ST, Faison T, Novara G, Karakiewicz PI, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Pycha A, Comploj E, Tilki D, Bastian PJ, Chun FK, Dahlem R, Scherr DS, Shariat SF

Predictors of cancer-specific mortality after disease recurrence following radical cystectomy.
BJU Int. 2012; [Epub ahead of print]
Rink M, Lee DJ, Kent M, Xylinas E, Fritsche HM, Babjuk M, Brisuda A, Hansen J, Green DA, Aziz A, Cha EK, Novara G, Chun FK, Lotan Y, Bastian PJ, Tilki D, Gontero P, Pycha A, Baniel J, Mano R, Ficarra V, Trinh QD, Tagawa ST, Karakiewicz PI, Scherr DS, Sjoberg DD, Shariat SF, for the Bladder Cancer Research Consortium

Animal models in urinary diversion.
BJU Int. 2012;109(1): 6-23
Roosen A, Woodhouse CR, Wood DN, Stief CG, McDougal WS, Gerharz EW

Effects on bladder function of combining elocalcitol and tolterodine in rats with outflow obstruction.
BJU Int. 2012; [Epub ahead of print]
Streng T, Andersson KE, Hedlund P, Gratzke C, Baroni E, D'Ambrosio D, Benigni F

Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.
BJU Int. 2012; [Epub ahead of print]
Tilki D, Shariat SF, Lotan Y, Rink M, Karakiewicz PI, Schoenberg MP, Lerner SP, Sonpavde G, Sagalowsky AI, Gupta A

Alterations of global histone H4K20 methylation during prostate carcinogenesis.
BMC Urol. 2012;12: 5
Behbahani TE, Kahl P, von der Gathen J, Heukamp LC, Baumann C, Gütgemann I, Walter B, Hofstädter F, Bastian PJ, von Ruecker A, Müller SC, Rogenhofer S, Ellinger J

Ciliary activity in the oviduct of cycling, pregnant, and muscarinic receptor knockout mice.
Biol Reprod. 2012;86(4): 120
Noreikat K, Wolff M, Kummer W, Kölle S

Inhibition of adrenergic human prostate smooth muscle contraction by the inhibitors of c-Jun N-terminal kinase, SP600125 and BI-78D3.
Br J Pharmacol. 2012; [Epub ahead of print]
Strittmatter F, Walther S, Gratzke C, Göttinger J, Beckmann C, Roosen A, Schlenker B, Hedlund P, Andersson KE, Stief CG, Hennenberg M

Outcome assessment of patients with metastatic renal cell carcinoma under systemic therapy using artificial neural networks.
Clin Genitourin Cancer. 2012;10(1): 37-42
Buchner A, Kendlbacher M, Nuhn P, Tüllmann C, Haseke N, Stief CG, Staehler M

An international expanded-access programme of everolimus: addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy.
Eur J Cancer. 2012;48(3): 324-32
Grünwald V, Karakiewicz PI, Bavbek SE, Miller K, Machiels JP, Lee SH, Larkin J, Bono P, Rha SY, Castellano D, Blank CU, Knox JJ, Hawkins R, Anak O, Rosamilia M, Booth J, Pirotta N, Bodrogi I, REACT Study Group , Romedi M, Ferrandini S, Rondinon M, Pittman K, Goldstein D, Shapiro J, Troon S, Yip D, Mainwaring P, Zigeuner R, Loidl W, Greil RF, Schmidinger M, De Grève J, Rottey S, Vermorken J, Machiels J, Gil T, Gennigens C, Roumeguere T, Barrios C, Mathias C, Assi H, Hotte S, Karakiewicz P, Knox J, Spadafora S, Wood L, Zalewski P, Mackensie M, Bjarnason G, Lalancette A, Chan A, Higgins B, North S, Soulieres D, Asselah J, Sperlich C, Miller W, Yadav S, El-Maraghi R, Godoy J, Prausová J, Katolicka J, Petruzelka L, Kiss I, Bono P, Lapela M, Miller K, Grünwald V, Bergmann L, Beck J, Jäger E, Kindler M, Overkamp F, Wirth M, Hölzer W, Gschwend J, Stenzl A, Gauler T, Niederwieser D, Marschner N, Lück A, Tessen H, Eichelberg C, Steiner T, Goebell P, Kettner E, Bakhshandeh-Bath A, Wilhelm M, Schmitz S, Jacob A, Bierer S, Kube U, Staehler M, Engel E, Frambach M, Schellenberger U, Albers P, Simon J, Gleissler M, Klotz T, Repp R, Kröning H, Westermann J, Rebmann U, Brehmer B, Niederle N, Grund C, Verpoort K, Fonara P, Rassweiler J, Bamias A, Fountzilas G, Razis E, Mouratidou D, Georgoulias V, Samantas E, Bodrogi I, Mangel L, Szanto J, Berger R, Pe'er A, Sella A, Ben-Yosef R, Nechushtan H, Crinò L, Bracarda S, Ciuffreda L, Graiff C, Falcone A, Roselli M, Sternberg C, Santoro A, Ruggeri E, Bearz A, Venturini M, Aglietta M, Amadori D, Di Costanzo F, Bari M, Gebbia N, Conte P, Bonetti A, Bordonaro R, Cascinu S, Contu A, Cruciani G, Gasparro D, Nardi M, Lelli G, Lo Re G, Boccardo F, Lorusso V, Maiello E, Manente P, Passalacqua R, Piantedosi F, Porta C, Sacco C, Tondini C, De Placido S, Carteni G, Dogliotto L, Rosti G, Milella M, Roila F, Amoroso D, Farina G, Al-Khatib H, Lee S, Kim T, Ahn J, Lim H, Rha S, Chung I, Kim J, Chung J, Ghosn M, Shameseddine A, Lugo R, Cabrera P, Osanto S, Groenewegen G, Blank C, van den Eertwegh F, van Herpen C, Oosting S, Soetekouw P, Lilleby W, Klepp O, Guren T, Alcedo J, Karlov P, Nosov D, Roman L, Rusakov I, Bazarbashi S, Toh C, Mardiak J, del Muro Solans FG, Ray JM, Mollins JB, Castellano D, Martinez ID, Gonzalez BM, Santasusana MD, Piqueras ML, Fuentes JC, Larriba JG, Caro RL, Garcia AM, Aparicio L, Lopez NB, Aragon VC, Morales CV, Figueiras M, Ibanez JC, Billalabeitia G, Estrada E, Arranz J, Sorrosal JL, Lozano A, de Villena MC, Espinosa E, Lopez R, Perez J, Laurell A, Stierner U, Cwikiel M, Borner M, Dietrich PY, Rothermundt C, Pu Y, Chang Y, Ou Y, Chuang C, Liao Y, Srimuninnimit V, Sriuranpong V, Bavbek S, Buyukberber S, Yalcin B, Goker E, Yalcin S, Geldart T, Wagstaff J, Nicholson S, Chowdhury S, Bahl A, Jones R, Azzabi A, Chao D, Fife K, Hawkins R, Larkin J, Mead G, Nathan P, Pandha H, Hajdenberg J, Gabrail N, Nimeh N, Logan T, Flaig T, Schraeder R, Rini B, O'Rourke M, Alemany C, Beck J, Kessinger A, Amin A, Arriaga M, Rodriguez J

Relationship between PSA kinetics and [¹?F]fluorocholine PET/CT detection rates of recurrence in patients with prostate cancer after total prostatectomy.
Eur J Nucl Med Mol Imaging. 2012;39(2): 271-82
Graute V, Jansen N, Ubleis C, Seitz M, Hartenbach M, Scherr MK, Thieme S, Cumming P, Klanke K, Tiling R, Bartenstein P, Hacker M

External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
Eur J Surg Oncol. 2012; [Epub ahead of print]
Nuhn P, May M, Fritsche HM, Buchner A, Brookman-May S, Bolenz C, Moritz R, Herrmann E, Burger M, Höfner T, Ellinger J, Tilki D, Roigas J, Zacharias M, Trojan L, Wülfing C, May F, Melchior S, Haferkamp A, Gilfrich C, Hohenfellner M, Wieland WF, Müller SC, Stief CG, Bastian PJ

Dual energy CT in patients with polycystic kidney disease.
Eur Radiol. 2012; [Epub ahead of print]
Arndt N, Staehler M, Siegert S, Reiser MF, Graser A

Laser treatment of benign prostatic obstruction: basics and physical differences.
Eur Urol. 2012;61(2): 317-25
Bach T, Muschter R, Sroka R, Gravas S, Skolarikos A, Herrmann TR, Bayer T, Knoll T, Abbou CC, Janetschek G, Bachmann A, Rassweiler JJ

180-W XPS GreenLight laser therapy for benign prostate hyperplasia: early safety, efficacy, and perioperative outcome after 201 procedures.
Eur Urol. 2012;61(3): 600-7
Bachmann A, Muir GH, Collins EJ, Choi BB, Tabatabaei S, Reich OM, Gómez-Sancha F, Woo HH

Contemporary management of ureteral stones.
Eur Urol. 2012;61(4): 764-72
Bader MJ, Eisner B, Porpiglia F, Preminger GM, Tiselius HG

High-risk prostate cancer: from definition to contemporary management.
Eur Urol. 2012;61(6): 1096-106
Bastian PJ, Boorjian SA, Bossi A, Briganti A, Heidenreich A, Freedland SJ, Montorsi F, Roach M, Schröder F, van Poppel H, Stief CG, Stephenson AJ, Zelefsky MJ

Onabotulinumtoxin A for Idiopathic Overactive Bladder: Raising the Bar.
Eur Urol. 2012; [Epub ahead of print]
Bauer RM, Gratzke C

A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes.
Eur Urol. 2012;61(4): 664-75
Boorjian SA, Eastham JA, Graefen M, Guillonneau B, Karnes RJ, Moul JW, Schaeffer EM, Stief C, Zorn KC

Features Associated with Recurrence Beyond 5 Years After Nephrectomy and Nephron-Sparing Surgery for Renal Cell Carcinoma: Development and Internal Validation of a Risk Model (PRELANE score) to Predict Late Recurrence Based on a Large Multicenter Database.
Eur Urol. 2012; [Epub ahead of print]
Brookman-May S, May M, Shariat SF, Xylinas E, Stief C, Zigeuner R, Chromecki T, Burger M, Wieland WF, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Feciche B, Truss M, Gilfrich C, Pahernik S, Hohenfellner M, Zastrow S, Wirth MP, Novara G, Carini M, Minervini A, Simeone C, Antonelli A, Mirone V, Longo N, Simonato A, Carmignani G, Ficarra V, members of the CORONA project and the SATURN project

Perioperative Betamethasone Treatment Reduces Signs of Bladder Dysfunction in a Rat Model for Neurapraxia in Female Urogenital Surgery.
Eur Urol. 2012; [Epub ahead of print]
Castiglione F, Bergamini A, Bettiga A, Bivalacqua TJ, Benigni F, Strittmatter F, Gandaglia G, Rigatti P, Montorsi F, Hedlund P

Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Eur Urol. 2012;61(4): 818-25
Cha EK, Shariat SF, Kormaksson M, Novara G, Chromecki TF, Scherr DS, Lotan Y, Raman JD, Kassouf W, Zigeuner R, Remzi M, Bensalah K, Weizer A, Kikuchi E, Bolenz C, Roscigno M, Koppie TM, Ng CK, Fritsche HM, Matsumoto K, Walton TJ, Ehdaie B, Tritschler S, Fajkovic H, Martínez-Salamanca JI, Pycha A, Langner C, Ficarra V, Patard JJ, Montorsi F, Wood CG, Karakiewicz PI, Margulis V

Extranodal Extension Is a Powerful Prognostic Factor in Bladder Cancer Patients with Lymph Node Metastasis.
Eur Urol. 2012;  [Epub ahead of print]
Fajkovic H, Cha EK, Jeldres C, Robinson BD, Rink M, Xylinas E, Chromecki TF, Breinl E, Svatek RS, Donner G, Tagawa ST, Tilki D, Bastian PJ, Karakiewicz PI, Volkmer BG, Novara G, Joual A, Faison T, Sonpavde G, Daneshmand S, Lotan Y, Scherr DS, Shariat SF

A Contemporary Update on Pathology Reporting for Prostate Cancer: Biopsy and Radical Prostatectomy Specimens.
Eur Urol. 2012; [Epub ahead of print]
Fine SW, Amin MB, Berney DM, Bjartell A, Egevad L, Epstein JI, Humphrey PA, Magi-Galluzzi C, Montironi R, Stief C

Prognostic Value of Perinodal Lymphovascular Invasion Following Radical Cystectomy for Lymph Node-positive Urothelial Carcinoma.
Eur Urol. 2012; [Epub ahead of print]
Fritsche HM, May M, Denzinger S, Otto W, Siegert S, Giedl C, Giedl J, Eder F, Agaimy A, Novotny V, Wirth M, Stief C, Brookman-May S, Hofstädter F, Gierth M, Aziz A, Kocot A, Riedmiller H, Bastian PJ, Toma M, Wieland WF, Hartmann A, Burger M

Of Mice and Men: Animal Models in Functional Urology.
Eur Urol. 2012; [Epub ahead of print]
Gratzke C

Alpha-Blockers and Antimuscarinics for Male Lower Urinary Tract Symptoms: The Search Goes On.
Eur Urol. 2012; [Epub ahead of print]
Gratzke C, Andersson KE

Laparoscopic Marsupialisation of Pelvic Lymphoceles in Different Anatomic Locations Following Radical Prostatectomy.
Eur Urol. 2012; [Epub ahead of print]
Khoder WY, Gratzke C, Haseke N, Herlemann A, Stief CG, Becker AJ

External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder.
Eur Urol. 2012;61(1): 58-64
Nuhn P, May M, Sun M, Fritsche HM, Brookman-May S, Buchner A, Bolenz C, Moritz R, Herrmann E, Burger M, Tilki D, Trojan L, Perrotte P, Haferkamp A, Hohenfellner M, Wieland WF, Müller SC, Karakiewicz PI, Bastian PJ

Treatment of Postprostatectomy Male Urinary Incontinence With the Transobturator Retroluminal Repositioning Sling Suspension: 3-Year Follow-up.
Eur Urol. 2012; [Epub ahead of print]
Rehder P, Haab F, Cornu JN, Gozzi C, Bauer RM

Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery.
Eur Urol. 2012;62(4): 677-84
Rink M, Ehdaie B, Cha EK, Green DA, Karakiewicz PI, Babjuk M, Margulis V, Raman JD, Svatek RS, Fajkovic H, Lee RK, Novara G, Hansen J, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Pycha A, Fisch M, Scherr DS, Shariat SF, Bladder Cancer Research Consortium (BCRC) , Upper Tract Urothelial Carcinoma Collaboration (UTUCC) , Bastian PJ, Bensalah K, Bolenz C, Chromecki TF, Dinney CP, Fernández M, Ficarra V, Fradet Y, Izawa JI, Kabbani W, Kikuchi E, Koppie TM, Lerner SP, Martinez-Salamanca JI, Matsumoto K, Montorsi F, Ng CK, Oya M, Patard JJ, Remzi M, Roscigno M, Sagalowsky AI, Schoenberg MP, Seitz C, Skinner E, Ströbel P, Tilki D, Tritschler S, Walton TJ, Weizer A, Wolf J, Wood CG, Zigeuner R

Prevention and management of postprostatectomy sexual dysfunctions part 2: recovery and preservation of erectile function, sexual desire, and orgasmic function.
Eur Urol. 2012;62(2): 273-86
Salonia A, Burnett AL, Graefen M, Hatzimouratidis K, Montorsi F, Mulhall JP, Stief C

Prevention and management of postprostatectomy sexual dysfunctions part 1: choosing the right patient at the right time for the right surgery.
Eur Urol. 2012;62(2): 261-72
Salonia A, Burnett AL, Graefen M, Hatzimouratidis K, Montorsi F, Mulhall JP, Stief C

Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment.
Eur Urol. 2012;61(2): 237-42
Shariat SF, Ehdaie B, Rink M, Cha EK, Svatek RS, Chromecki TF, Fajkovic H, Novara G, David SG, Daneshmand S, Fradet Y, Lotan Y, Sagalowsky AI, Clozel T, Bastian PJ, Kassouf W, Fritsche HM, Burger M, Izawa JI, Tilki D, Abdollah F, Chun FK, Sonpavde G, Karakiewicz PI, Scherr DS, Gonen M

Sequencing of agents for metastatic renal cell carcinoma: can we customize therapy?
Eur Urol. 2012;61(2): 307-16
Sonpavde G, Choueiri TK, Escudier B, Ficarra V, Hutson TE, Mulders PF, Patard JJ, Rini BI, Staehler M, Sternberg CN, Stief CG

Expression of Fatty Acid Amide Hydrolase (FAAH) in Human, Mouse, and Rat Urinary Bladder and Effects of FAAH Inhibition on Bladder Function in Awake Rats.
Eur Urol. 2012;61(1): 98-106
Strittmatter F, Gandaglia G, Benigni F, Bettiga A, Rigatti P, Montorsi F, Gratzke C, Stief C, Colciago G, Hedlund P

18F-Fluoroethylcholine PET/CT Identifies Lymph Node Metastasis in Patients with Prostate-Specific Antigen Failure After Radical Prostatectomy but Underestimates Its Extent.
Eur Urol. 2012; [Epub ahead of print]
Tilki D, Reich O, Graser A, Hacker M, Silchinger J, Becker AJ, Khoder W, Bartenstein P, Stief CG, Loidl W, Seitz M

Mesenchymal stem cells and glioma cells form a structural as well as a functional syncytium in vitro.
Exp Neurol. 2012;234(1): 208-19
Schichor C, Albrecht V, Korte B, Buchner A, Riesenberg R, Mysliwietz J, Paron I, Motaln H, Turn?ek TL, Jürchott K, Selbig J, Tonn JC

Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large german multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder.
Gend Med. 2012;9(6): 481-9
Otto W, May M, Fritsche HM, Dragun D, Aziz A, Gierth M, Trojan L, Herrmann E, Moritz R, Ellinger J, Tilki D, Buchner A, Höfner T, Brookman-May S, Nuhn P, Gilfrich C, Roigas J, Zacharias M, Denzinger S, Hohenfellner M, Haferkamp A, Müller SC, Kocot A, Riedmiller H, Wieland WF, Stief CG, Bastian PJ, Burger M

Tumor vessel stabilization and remodeling by anti-angiogenic therapy with bevacizumab.
Histochem Cell Biol. 2012;137(3): 391-401
Weißhardt P, Trarbach T, Dürig J, Paul A, Reis H, Tilki D, Miroschnik I, Ergün S, Klein D

Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancer.
Int J Cancer. 2012;130(12): 2922-9
Szarvas T, László V, Vom Dorp F, Reis H, Szendr?i A, Romics I, Tilki D, Rübben H, Ergün S

Increased expression of nestin in the major pelvic ganglion following cavernous nerve injury.
Int J Impot Res. 2012;24(2): 84-90
Kutlu O, Ross AE, Schaeffer EM, Gratzke C, Stief CG, Strong TD, Burnett AL, Hedlund P, Bivalacqua TJ

The impact of bladder neck mucosal eversion during open radical prostatectomy on bladder neck stricture and urinary extravasation.
Int Urol Nephrol. 2012; 44(5): 1403-10
Schoeppler GM, Zaak D, Clevert DA, Schuhmann P, Reich O, Seitz M, Khoder WY, Staehler M, Stief CG, Buchner A

Nephron-sparing resection of angiomyolipoma after sirolimus pretreatment in patients with tuberous sclerosis.
Int Urol Nephrol. 2012; 44(6): 1657-61
Staehler M, Sauter M, Helck A, Linsenmaier U, Weber L, Mayer K, Fischereder M

Loss of the mammal-specific tectorial membrane component CEA cell adhesion molecule 16 (CEACAM16) leads to hearing impairment at low and high frequencies.
J Biol Chem. 2012; [Epub ahead of print]
Kammerer R, Ruettiger L, Riesenberg R, Schaeuble C, Krupar R, Kamp A, Sunami K, Eisenried A, Hennenberg M, Grunert F, Bress A, Battaglia S, Schrewe H, Knipper M, Schneider MR, Zimmermann W

Ex vivo comparison of the tissue effects of six laser wavelengths for potential use in laser supported partial nephrectomy.
J Biomed Opt. 2012;17(6): 068005
Khoder WY, Zilinberg K, Waidelich R, Stief CG, Becker AJ, Pangratz T, Hennig G, Sroka R

Transcript signature predicts tissue NK cell content and defines renal cell carcinoma subgroups independent of TNM staging.
J Mol Med. 2012;90(1): 55-66
Eckl J, Buchner A, Prinz PU, Riesenberg R, Siegert SI, Kammerer R, Nelson PJ, Noessner E

Monitoring the coupling of the lithotripter therapy head with skin during routine shock wave lithotripsy with a surveillance camera.
J Urol. 2012;187(1): 157-63
Bohris C, Roosen A, Dickmann M, Hocaoglu Y, Sandner S, Bader M, Stief CG, Walther S

Spinal Cord Fatty Acid Amide Hydrolase (FAAH) in Normal Micturition Control and Bladder Overactivity in Awake Rats.
J Urol. 2012; [Epub ahead of print]
Füllhase C, Russo A, Castiglione F, Benigni F, Campeau L, Montorsi F, Gratzke C, Bettiga A, Stief C, Andersson KE, Hedlund P

Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy.
J Urol. 2012;188(1): 58-62
Grossman HB, Stenzl A, Fradet Y, Mynderse LA, Kriegmair M, Witjes JA, Soloway MS, Karl A, Burger M

Inhibition of Rho-kinase Improves Erectile Function, Increases Nitric Oxide Signaling and Decreases Penile Apoptosis in a Rat Model of Cavernous Nerve Injury.
J Urol. 2012; [Epub ahead of print]
Hannan JL, Albersen M, Kutlu O, Gratzke C, Stief CG, Burnett AL, Lysiak JJ, Hedlund P, Bivalacqua TJ

External validation of a risk model to predict recurrence-free survival after radical cystectomy in patients with pathological tumor stage T3N0 urothelial carcinoma of the bladder.
J Urol. 2012;187(4): 1210-4
May M, Bastian PJ, Brookman-May S, Fritsche HM, Bolenz C, Gilfrich C, Otto W, Trojan L, Herrmann E, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Nuhn P, Burger M

Risk stratification of organ confined bladder cancer after radical cystectomy using cell cycle related biomarkers.
J Urol. 2012;187(2): 457-62
Shariat SF, Chromecki TF, Cha EK, Karakiewicz PI, Sun M, Fradet Y, Isbarn H, Scherr DS, Bastian PJ, Pummer K, Fajkovic H, Sagalowsky AI, Ashfaq R, Doblinger M, Cote RJ, Lotan Y

Stem cell therapy ameliorates bladder dysfunction in an animal model of Parkinson disease.
J Urol. 2012;187(4): 1491-7
Soler R, Füllhase C, Hanson A, Campeau L, Santos C, Andersson KE

Encrustation of urologic double pigtail catheters-an ex vivo optical coherence tomography (OCT) study.
Lasers Med Sci. 2012; [Epub ahead of print]
Bader MJ, Zilinberg K, Weidlich P, Waidelich R, Püls M, Gratzke C, Stief CG, Stepp H, Sroka R

In vitro investigations of repulsion during laser lithotripsy using a pendulum set-up.
Lasers Med Sci. 2012;27(3): 637-43
Sroka R, Haseke N, Pongratz T, Hecht V, Tilki D, Stief CG, Bader MJ

Activation of protein kinase B/Akt by alpha1-adrenoceptors in the human prostate.
Life Sci. 2012;90(11-12): 446-53
Strittmatter F, Walther S, Roosen A, Rutz B, Schlenker B, Limmer S, Waidelich R, Stief CG, Gratzke C, Hennenberg M

[Early diagnosis of prostate cancer].
MMW Fortschr Med. 2012;154(1): 43-6
Hocaoglu Y, Seitz M, Stief CG, Bastian PJ

[You have to take the prostate cancer seriously].
MMW Fortschr Med. 2012;154(1): 42
Stief CG

[Management of prostate cancer].
MMW Fortschr Med. 2012;154(1): 47-50
Zilinberg K, Roosen A, Belka C, Ganswindt U, Stief CG

Live cell imaging of the oviduct.
Methods Enzymol. 2012;506: 415-23
Kölle S

Interventional therapies for lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH).
Minerva Urol Nefrol. 2012;64(2): 123-33
Seitz M, Bader M, Tilki D, Stief C, Gratzke C

High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients following tumor cell vaccination.
Mol Med. 2012; [Epub ahead of print]
Pohla H, Buchner A, Stadlbauer B, Frankenberger B, Stevanovic S, Walter S, Frank R, Schwachula T, Olek S, Kopp J, Willimsky G, Stief CG, Hofstetter A, Pezzutto A, Blankenstein T, Oberneder R, Schendel DJ

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival.
Nat Med. 2012; [Epub ahead of print]
Walter S, Weinschenk T, Stenzl A, Zdrojowy R, Pluzanska A, Szczylik C, Staehler M, Brugger W, Dietrich PY, Mendrzyk R, Hilf N, Schoor O, Fritsche J, Mahr A, Maurer D, Vass V, Trautwein C, Lewandrowski P, Flohr C, Pohla H, Stanczak JJ, Bronte V, Mandruzzato S, Biedermann T, Pawelec G, Derhovanessian E, Yamagishi H, Miki T, Hongo F, Takaha N, Hirakawa K, Tanaka H, Stevanovic S, Frisch J, Mayer-Mokler A, Kirner A, Rammensee HG, Reinhardt C, Singh-Jasuja H

Silodosin Inhibits Noradrenaline-Activated Transcription Factors Elk1 and SRF in Human Prostate Smooth Muscle.
PLoS ONE. 2012;7(11): e50904
Hennenberg M, Strittmatter F, Beckmann C, Rutz B, Füllhase C, Waidelich R, Montorsi F, Hedlund P, Andersson KE, Stief CG, Gratzke C

[Ketamine-induced vesicopathy].
Psychiatr Prax. 2012;39(1): 43-5
Lieb M, Bader M, Palm U, Stief CG, Baghai TC

Predictive factors for urinary retention following kidney transplantation in male patients.
Scand J Urol Nephrol. 2012;46(1): 44-7
Gratzke C, Pahde A, Dickmann M, Reich O, Seitz M, Jauch K, Stief CG, Siebels M

Urine colour after radical prostatectomy predicts urinary leakage at the vesicourethral anastomosis.
Scand J Urol Nephrol. 2012; 46(5): 337-42
Schoeppler GM, Zaak D, Schuhmann P, Stief CG, Buchner A

Photodynamic Therapy of Bladder Cancer - A Phase I Study Using Hexaminolevulinate (HAL).
Urol Oncol. 2012; [Epub ahead of print]
Bader MJ, Stepp H, Beyer W, Pongratz T, Sroka R, Kriegmair M, Zaak D, Welschof M, Tilki D, Stief CG, Waidelich R

Circulating mitochondrial DNA in serum: a universal diagnostic biomarker for patients with urological malignancies.
Urol Oncol. 2012;30(4): 509-15
Ellinger J, Müller DC, Müller SC, Hauser S, Heukamp LC, von Ruecker A, Bastian PJ, Walgenbach-Brunagel G

Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma.
Urol Oncol. 2012;30(5): 666-72
Fritsche HM, Novara G, Burger M, Gupta A, Matsumoto K, Kassouf W, Sircar K, Zattoni F, Walton T, Tritschler S, Baba S, Bastian PJ, Martínez-Salamanca JI, Seitz C, Otto W, Wieland WF, Karakiewicz PI, Ficarra V, Hartmann A, Shariat SF

Course of size and density of metastatic renal cell carcinoma lesions in the early follow-up of molecular targeted therapy.
Urol Oncol. 2012;30(5): 695-703
Hittinger M, Staehler M, Schramm N, Ubleis C, Becker C, Reiser M, Berger F

Detection of inguinal lymph node involvement in penile squamous cell carcinoma by 18F-fluorodeoxyglucose PET/CT: a prospective single-center study.
Urol Oncol. 2012;30(1): 55-9
Schlenker B, Scher B, Tiling R, Siegert S, Hungerhuber E, Gratzke C, Tilki D, Reich O, Schneede P, Bartenstein P, Stief CG, Seitz M

Feasibility and effects of high-dose hypofractionated radiation therapy and simultaneous multi-kinase inhibition with sunitinib in progressive metastatic renal cell cancer.
Urol Oncol. 2012;30(3): 290-3
Staehler M, Haseke N, Stadler T, Nuhn P, Roosen A, Stief CG, Wilkowski R

Ureterorenoscopic biopsy and urinary cytology according to the 2004 WHO classification underestimate tumor grading in upper urinary tract urothelial carcinoma.
Urol Oncol. 2012; [Epub ahead of print]
Straub J, Strittmatter F, Karl A, Stief CG, Tritschler S

[New treatment strategies for male lower urinary tract symptoms].
Urologe A. 2012;51(12): 1697-702
Arenas da Silva LF, Schönthaler M, Cruz F, Gratzke C, Zumbe J, Stenzl A, Amend B, Sievert KD

[Focal prostate cancer therapy : Capabilities, limitations and prospects.]
Urologe A. 2012;[Epub ahead of print]
Baumunk D, Blana A, Ganzer R, Henkel T, Köllermann J, Roosen A, Machtens S, Salomon G, Sentker L, Witzsch U, Köhrmann KU, Schostak M, Arbeitsgruppe für Fokale und Mikrotherapie

[Partial nephrectomy : Rationale and limitations of an organ-preserving approach.]
Urologe A. 2012;[Epub ahead of print]
Casuscelli J, Gratzke C, Stief CG, Staehler M

[Surgical treatment of male lower urinary tract symptoms (LUTS)].
Urologe A. 2012;51(9): 1297-306; quiz 1307
Gratzke C, Strittmatter F, Reich O, Bachmann A, Stief CG, Seitz M

[Secondary malignancies in urinary diversions].
Urologe A. 2012;51(4): 500-6
Kälble T, Hofmann I, Thüroff JW, Stein R, Hautmann R, Riedmiller H, Vergho D, Hertle L, Wülfing C, Truß M, Roth S, von Rundstedt FC, Albers P, Gschwend J, Herkommer K, Humke U, Spahn M, Bader P, Steffens J, Harzmann R, Stief CG, Karl A, Müller SC, Waldner M, Noldus J, Kleinschmidt K, Alken P, Kopper B, Fisch M, Lampel A, Stenzel A, Fichtner J, Flath B, Rübben H, Juenemann KP, Hautmann S, Knipper A, Leusmann D, Strohmaier W, Thon WF, Miller S, Weingärtner K, Schilling A, Piechota H, Becht JE, Schwaibold H, Bub P, Conrad S, Wenderoth U, Merkle W, Rösch W, Otto T, Ulshöfer B, Westenfelder M

[Medical therapy of lower urinary tract symptoms [corrected]].
Urologe A. 2012;51(8): 1125-36
Strittmatter F, Madersbacher S, Stief CG, Gratzke C

Open complete intrafascial nerve-sparing retropubic radical prostatectomy: technique and initial experience.
Urology. 2012;79(3): 717-21
Khoder WY, Schlenker B, Waidelich R, Buchner A, Kellhammer N, Stief CG, Becker AJ

Interobserver Variability Limits Exact Preoperative Staging by Computed Tomography in Bladder Cancer.
Urology. 2012; [Epub ahead of print]
Tritschler S, Mosler C, Tilki D, Buchner A, Stief C, Graser A

Expression and Alpha1-adrenoceptor Regulation of Caldesmon in Human Prostate Smooth Muscle.
Urology. 2012;79(3): 745.e5-745.e12
Walther S, Strittmatter F, Roosen A, Heinzer F, Rutz B, Stief CG, Gratzke C, Hennenberg M

Tyrosine kinase expression profile in clear cell renal cell carcinoma.
World J Urol. 2012;30(4): 559-65
Behbahani TE, Thierse C, Baumann C, Holl D, Bastian PJ, von Ruecker A, Müller SC, Ellinger J, Hauser S

Microbial colonization and ureteral stent-associated storage lower urinary tract symptoms: the forgotten piece of the puzzle?
World J Urol. 2012; [Epub ahead of print]
Bonkat G, Rieken M, Müller G, Roosen A, Siegel FP, Frei R, Wyler S, Gasser T, Bachmann A, Widmer AF

Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective series.
World J Urol. 2012; [Epub ahead of print]
Brookman-May S, May M, Ficarra V, Kainz MC, Kampel-Kettner K, Kohlschreiber S, Wenzl V, Schneider M, Burger M, Wieland WF, Otto W, Tilki D, Gilfrich C, Hohenfellner M, Pahernik S, Chromecki TF, Stief C, Zigeuner R, Members of the CORONA (Collaborative Research On Renal Neoplasms Association) Project

Oncologic outcomes obtained after neoadjuvant and adjuvant chemotherapy for the treatment of urothelial carcinomas of the upper urinary tract: a review.
World J Urol. 2012; [Epub ahead of print]
Cordier J, Sonpavde G, Stief CG, Tilki D

Feasibility of radical cystectomy in exclusive spinal and/or epidural anaesthesia.
World J Urol. 2012; [Epub ahead of print]
Karl A, Schneevoigt B, Weninger E, Grimm T, Stief C

Novel options for the treatment of castration-resistant prostate cancer.
World J Urol. 2012;30(4): 495-503
Ohlmann CH, Merseburger AS, Suttmann H, Schilling D, Trojan L, Kempkensteffen C, Corvin S, Mathers MJ, Bastian PJ

Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?
World J Urol. 2012; [Epub ahead of print]
Rink M, Shariat SF, Xylinas E, Fitzgerald JP, Hansen J, Green DA, Kamat AM, Novara G, Daneshmand S, Fradet Y, Tagawa ST, Bastian PJ, Kassouf W, Trinh QD, Karakiewicz PI, Fritsche HM, Tilki D, Chun FK, Volkmer BG, Babjuk M, Merseburger AS, Scherr DS, Lotan Y, Svatek RS

Morphology and dynamics of the male pelvic floor before and after retrourethral transobturator sling placement: first insight using MRI.
World J Urol. 2012; [Epub ahead of print]
Soljanik I, Bauer RM, Becker AJ, Stief CG, Gozzi C, Soljanik O, Kirchhoff SM

Risk factors of treatment failure after retrourethral transobturator male sling.
World J Urol. 2012;30(2): 201-6
Soljanik I, Gozzi C, Becker AJ, Stief CG, Bauer RM